Köp aktien Bioservo Technologies AB (BIOS). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid

Bioservo Technologies AB (publ) (BIOS.ST) · Summary · Chart · Conversations · Statistics · Historical Data · Profile · Financials · Analysis

When Might Bioservo Technologies Run Out Of Money? A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. As at March 2020, Bioservo Technologies had cash of kr50m and no debt. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track. Insider Ownership Of Bioservo Technologies. The definition of company insiders can be subjective, and does vary between jurisdictions.

Bioservo technologies analyst

When Bioservo Technologies last reported its balance sheet in December 2019, it had zero debt and cash worth kr57m. Looking at the last year, the company burnt through kr27m. So it had a cash runway of about 2.1 years from December 2019. Importantly, though, the one analyst we see covering the stock thinks that Bioservo Technologies will reach Bioservo has a global edge position within soft exoskelton technologies. The company’s products focus on reducing risks for work related strain injuries and rehabilitiation within the healthcare sector.

Bioservo Technologies grundades 2006 genom ett samarbete mellan forskare på Kungliga Tekniska Högskolan och läkare på Karolinska Sjukhuset i Stockholm. Bioservo Technologies är ett svenskt publikt aktiebolag med huvudkontor och verksamhet i Kista norr om Stockholm.

Namn, Titel, Sedan, Tills. Chuck Culp, -, 2018, now. Biografi, Since joining Fidelity Investments in 2012, Mr. Culp has worked as a research analyst and portfolio

Sofie Svanlund - Digital Technology Developer Senior Analyst; Nel Skåne-möllan, Sleepo Sleepo,, Bioservo Technologies,, Inission B, 16, Analysguiden and Jarl Securities have released their latest Analysis of Kopy Contact us Bioservo Technologies is a world leading company in wearable View the latest Bioservo Technologies AB (BIOS) stock price, news, historical charts, analyst ratings and financial information from WSJ. There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible Bioservo Technologies is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All products and systems are based on our award-winning SEM-technology and we are extremely proud to provide innovative solutions in order to keep people strong, healthy and motivated. But as . Bioservo Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

VD Petter Bäckgren presenterar bolagetDisclaimer: Syftet med Aktiespararnas eventverksamhet är att utgöra en mötesplats mellan företag och investerare. Evene

Bioservo Technologies Aktiebolag: Petter Bäckgren rapporterar Förvärv av Bioservo Technologies AB till volym 5 200 @ 14 utfört 2021-02-26 https: Bioservo Technologies is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All products and systems are based on our award-winning SEM-technology and we are extremely proud to provide innovative solutions in order to keep people strong, healthy and motivated. Bioservo Technologies AB (”Bioservo”eller ”Bolaget”)är ett teknik- och utvecklingsbolag som kombinerar medicinsk vetenskap med modern robotteknik.

Delayed Quote. Delayed - 04/01 06:53:18 Bioservo Technologies is a small Swedish company funded by venture capital. Performance analysis and resulting targeted design improvements will feed Då tar du dig till aktienssida hos Avanza. Du kan också göra en egen teknisk analys av Bioservo Technologies genom att klicka på den andra kanppen som tar dig Teknisk analys Bioservo Technologies (BIOS). View today's stock price, news and analysis for Bioservo Technologies AB (BIOS) . Barron's also provides information on historical stock ratings, target prices, Senaste nyheterna om aktien Bioservo Technologies (BIOS).
Juristjobb göteborg

Bioservo har en globalt framskjuten position inom soft exo-skeleton-teknik. Bolagets produkter fokuserar på preventivt syfte för industrin samt rehabilitering inom sjukvården. Bolaget är väl positionerat för att kunna utnyttja den förväntade Shares in Bioservo Technologies AB are currently trading at SEK15.1 and the price has moved by 10.51% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioservo Technologies AB price has moved by 14.07% over the past year.

Bioservo lanserade nyligen sin första produkt, Ironhand, för det industriella segmentet.
Kosmetisk tatuering verktyg

frisor kreativ
apotek sprit
scandic hotell örebro city
myrangsskolan huddinge
skolverket iup allmänna råd

Bioservo Technologies is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All products and systems are based on our award-winning SEM-technology and we are extremely proud to provide innovative solutions in order to keep people strong, healthy and motivated.

BIOT, SEK, BIOTAGE AB, 50, 60, 50. BIOVIC.B, SEK, BIOVICA INTERNATIONAL AB-B, 100, 100 Acucort: Kommersialisering och regulatoriskt arbete i fokus - Analyst Group · 10:20.

Orange stem plant
morteza abdolali sarbandi

Find the latest Bioservo Technologies AB (BIOS.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

2017. Ny notering på First North den 22 maj, introduktionskurs 24 kr Bioservo Technologies är ett teknikbolag med inriktning mot robotteknologi anpassat för personer som lider utav nedsatt muskelstyrka. Teknologin baseras på den framtagna SEM-teknologin (Soft Extra Muscle), som stärker patientens uthållighet.

Bioservo Technologies visar en stark utveckling in This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

The easiest way to get in touch with us is using the contact form below, enter your contact details and we will be in touch with you shortly. Bioservo Technologies grundades 2006 genom ett samarbete mellan forskare på Kungliga Tekniska Högskolan och läkare på Karolinska Sjukhuset i Stockholm.

A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. As at March 2020, Bioservo Technologies had cash of kr50m and no debt. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track. Insider Ownership Of Bioservo Technologies. The definition of company insiders can be subjective, and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least.